99 Acquisition in a proxy filing laid out the terms of its proposed merger with Nava Health MD. The deal was announced in February at a potential equity value of $320 million. Terms call for the issuance of 32 million shares to Nava Health MD investors.
The target is a vertically integrated, tech-enabled chain of healthcare centers that combines integrative, functional, preventive, and regenerative medicine.
If approved, upon closing Nava Health MD expects to list on the Nasdaq.
The SPAC raised $75 million in an August IPO, initially with plans to focus on identifying businesses in the real estate industry. Read more.
